Industry Miniseries: Dr. Jim Musser and Dr. Camille Leugers

05/12/20 • 23 min

For our latest Industry Miniseries conversation, we had the pleasure of speaking with two University of Rochester School of Medicine and Dentistry graduates and life-partners, Dr. Jim Musser ’88MD, ’88M (PhD) and Dr. Camille Leugers ’88M (MD),’91M (Res). As the Chair of the Department of Pathology and Genomic Medicine and the Director of the Center for Molecular and Translational Human Infectious Diseases Research at Houston Methodist Hospital, Dr. Musser's work has been consumed by the recent pandemic of COVID-19. In an effort to treat COVID-19 patients, the team at Houston Methodist was the first in the nation to test an experimental blood transfusion therapy. Dr. Camille Leugers has also seen first-hand the impacts of COVID-19 as a family physician and faculty member of the brand new University of Houston College of Medicine which will welcome their first class in July of 2020. Tune in as they reminisce about their time at URMC, discuss how this recent pandemic has impacted the medical field and what things may look like going forward, and advice that they have for students.

Previous Episode

Industry Miniseries: Rosanna Moore '19DMA, Musician

Rosanna Moore is a freelance musician from the UK who attended Eastman School of Music where she recieved her Master of Music and Doctor of Musical Arts degrees in Harp Performance. She teaches Harp performance at Nazareth College and Eastman Community Music School, performs as a member of the Rochester Philharmonic Orchestra and Orchestra of the Southern Finger Lakes, and keeps herself busy with various gigs. Join us as we learn more about how COVID-19 has disrupted her industry and what advice she has for getting through this time.

Next Episode

Industry Miniseries: Mike McCormick '04, Ygrene Energy Fund

Mike McCormick graduated from the University of Rochester in 2004 and is the Director of Capital Markets at Ygrene Energy Fund. In this episode, we learn more about Mike's work and how COVID-19 has disrupted his industry. He also shares lessons he learned while transitioning from Bear Stearns & Co. to Ambac during the Great Recession in 2008-2009.